**Core Concept**
Platelet function is a critical aspect of hemostasis, the process by which the body stops bleeding after injury. Platelets, also known as thrombocytes, play a key role in this process by aggregating and forming a platelet plug to prevent excessive blood loss. Assessing platelet function is essential in diagnosing and managing bleeding disorders.

**Why the Correct Answer is Right**
The correct answer is the Bleeding Time (BT) test, also known as the Ivy or Duke method. This test measures the time it takes for bleeding to stop after a standardized incision is made on the skin. The bleeding time is influenced by platelet count, platelet function, and vascular integrity. In individuals with platelet function disorders, such as Glanzmann thrombasthenia, the bleeding time is prolonged.

**Option A:** is incorrect because the Prothrombin Time (PT) test evaluates the extrinsic coagulation pathway, specifically the factors involved in blood clotting. While PT can indicate coagulopathy, it does not directly assess platelet function.

**Option B:** is incorrect because the Partial Thromboplastin Time (PTT) test evaluates the intrinsic and common coagulation pathways, also not directly related to platelet function.

**Option C:** is incorrect because the Ristocetin Cofactor Assay specifically measures the von Willebrand factor (VWF) activity, which is related to von Willebrand disease, but not directly assessing platelet function.

**Clinical Pearl / High-Yield Fact**
The bleeding time test is a useful screening tool for platelet function disorders, but it is not always reliable in patients with thrombocytopenia (low platelet count) or in the presence of antiplatelet medications.

**Correct Answer:** B. Partial Thromboplastin Time (PTT) test is not the correct answer, as the correct answer should be one of the options provided.